Oxygenta Pharmaceutical Ltd — Board Meeting, 30-05-2025: Board Meeting

Oxygenta Pharmaceutical Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported revenue from operations of Rs 49.47 Cr for the quarter, significantly higher than Rs 10.55 Cr in the same quarter last year. However, it recorded a loss before tax of Rs 3.80 Cr for the quarter, wider than the previous year's Rs 2.59 Cr loss. For the full year, revenue rose to Rs 109.30 Cr, but it sustained a loss before tax of Rs 14.35 Cr. The company also shifted its corporate office within Hyderabad. Management continues efforts to identify MSME creditors accurately and improve creditor reporting processes. The statutory auditors issued an unmodified opinion on the financials.